| name | endo-fha-mullerian-anomalies-primary-amenorrhea |
| description | This skill guides clinicians to evaluate congenital or acquired Müllerian tract anomalies in patients with primary amenorrhea using physical exam, progestin challenge test, and imaging. Trigger phrases include 'Rule out imperforate hymen with exam' or 'Consider ultrasound for Müllerian anomalies'. |
Evaluate Müllerian tract anomalies in primary amenorrhea
STEP 1 — Gather Information
Confirm primary amenorrhea (no menarche by age >15 with secondary sexual characteristics or >13 without). Obtain detailed history: menstrual, developmental, surgical, symptoms of pelvic pain or cyclic discomfort. Perform external genital exam; if tolerated, bimanual exam to assess vaginal length, cervical position, and uterine size. Look for imperforate hymen (bluish bulge), vaginal septum, or absent vaginal canal.
STEP 2 — Rule In / Rule Out
Is there an obvious obstructive lesion on physical exam (e.g., imperforate hymen, transverse vaginal septum)?
- Yes → Rule in obstructive outflow tract anomaly; proceed to STEP 3 for anatomic confirmation.
- No → Rule out obvious obstructive lesion; proceed to progestin challenge test to assess estrogen exposure and tract patency.
STEP 3 — Classify or Stratify
If obstructive lesion suspected:
- Obtain pelvic ultrasound (abdominal or transvaginal) or MRI to confirm anatomy (e.g., hematocolpos, uterine presence).
If no obstructive lesion:
- Administer progestin challenge (e.g., medroxyprogesterone acetate 10 mg daily for 5–10 days).
- Withdrawal bleeding → Adequate estrogen and patent outflow tract; consider functional hypothalamic amenorrhea or endocrine evaluation.
- No withdrawal bleeding → Low estrogen or occult anatomic anomaly; obtain pelvic ultrasound/MRI to differentiate Müllerian agenesis (e.g., MRKH syndrome) from Asherman syndrome or other acquired causes.
STEP 4 — Decide
- Obstructive anomaly confirmed (imperforate hymen, septum, vaginal agenesis with hematocolpos): Refer for surgical correction (hymenectomy, septal resection, vaginoplasty).
- Müllerian agenesis confirmed (absent uterus/vagina, normal ovaries): Provide counseling, discuss surgical neovagina creation, psychosocial support, and fertility options (uterine transplant, gestational carrier).
- Asherman syndrome suspected (history of uterine instrumentation, scarring): Perform hysteroscopy for lysis of adhesions.
- No anatomic anomaly, low estrogen: Proceed to endocrine workup for functional hypothalamic amenorrhea (FHA) per guideline Section 2.1–2.7.
- Estrogen adequate, no bleeding, normal anatomy: Consider rare causes (cervical stenosis, endometriosis) and pursue further gynecologic evaluation.
Clinical Guardrails / Mimics / Pitfalls
Do not assume primary amenorrhea is solely due to FHA; always exclude anatomic causes first. Avoid progestin challenge when an obstructive lesion is visible on exam (risk of pain or hematometra). Do not rely on hormone levels alone to rule out Müllerian anomalies. MRI is the gold standard for evaluating uterine and vaginal anatomy when ultrasound is inconclusive. Remember that imperforate hymen can present with cyclic pelvic pain without visible bleeding.
Concrete Clinical Example
A 16‑year‑old with breast development (Tanner stage 4) reports never having a period. External exam reveals a tense, bluish bulge at the vaginal introitus consistent with an imperforate hymen. Progestin challenge is deferred. Hymenectomy is performed, yielding immediate dark blood flow and subsequent menarche.
Source: Functional Hypothalamic Amenorrhea: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2017, doi:10.1210/jc.2017-00131
